|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/564 | |
| G01N 33/574 | |||
| G01N 33/74 | |||
| A61K 39/395 |
| (11) | Number of the document | 3102943 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15702275.7 |
| Date of filing the European patent application | 2015-02-03 | |
| (97) | Date of publication of the European application | 2016-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/052188 |
| Date | 2015-02-03 |
| (87) | Number | WO 2015/117955 |
| Date | 2015-08-13 |
| (30) | Number | Date | Country code |
| 14153825 | 2014-02-04 | EP |
| (72) |
HEIDECKE, Harald, DE
SCHULZE-FORSTER, Kai, DE
|
| (73) |
CellTrend GmbH,
Im Biotechnologiepark, 14943 Luckenwalde,
DE
|
| (54) | DIAGNOSIS OF CANCER BY DETECTING AUTO-ANTIBODIES AGAINST VASCULAR ENDOTHELIALGROWTH FACTOR RECEPTOR (VEGFR) |
| DIAGNOSIS OF CANCER BY DETECTING AUTO-ANTIBODIES AGAINST VASCULAR ENDOTHELIALGROWTH FACTOR RECEPTOR (VEGFR) |